Edwards Lifesciences Debt Current Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 141.31  1.91  1.37%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Debt Current of Edwards Lifesciences Corporation with missing and latest data points interpolated. The current portion of Total Debt, reported if the company operates a classified balance sheet that segments current and non-current liabilities.
Debt Current  10 Years Trend  
 Debt Current 

Edwards Lifesciences Debt Current Over Time

2016-12-31  41,800,000 
2017-12-31  41,800,000 
2018-12-31  49,176,471 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  47,559,729
Geometric Mean  35,299,581
Coefficient Of Variation  69.17
Mean Deviation  16,008,771
Median  41,800,000
Standard Deviation  32,897,409
Range  148,900,000
R Value (0.16)
R Squared  0.026983
Significance  0.59
Slope (1,387,589)

Currently Trending

Purchased over 500 shares of
few hours ago ago
Traded for 5.25
Purchased over 70 shares of
few hours ago ago
Traded for 34.98
Purchased over 30 shares of
few hours ago ago
Traded for 92.89